Biopta and Proteon publish new research in Journal of Cardiovascular Pharmacology

A new paper in the Journal of Cardiovascular Pharmacology describes a potential treatment for atherosclerosis. Proteon Therapeutics, Waltham, MA, has developed a recombinant pancreatic elastase that was tested for its ability to dilate atherosclerotic human arteries, ethically obtained from patients with peripheral artery disease and set up at Biopta's human tissue research facility in Scotland.

A free download of the article is available at www.ncbi.nlm.nih.gov/pmc/articles/PMC4272232/pdf/jcvp-64-530.pdf